NH SPAC 5 (215790) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NH SPAC 5 (215790) has a cash flow conversion efficiency ratio of -0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.48 Billion ≈ $-1.00 Million USD) by net assets (₩35.95 Billion ≈ $24.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NH SPAC 5 - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how NH SPAC 5's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NH SPAC 5 total liabilities for a breakdown of total debt and financial obligations.
NH SPAC 5 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NH SPAC 5 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jia Jie Biomedical Co Ltd
TWO:4109
|
0.000x |
|
CANTOURAGE GROUP SE O.N.
F:HIGH
|
N/A |
|
Banswara Syntex Limited
NSE:BANSWRAS
|
0.035x |
|
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ:ZYBT
|
N/A |
|
DENARIUS METALS CORP.
F:T7C0
|
N/A |
|
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA
|
-0.145x |
|
Ezwelfare Co Ltd
KQ:090850
|
0.020x |
|
Cyviz AS
OL:CYVIZ
|
0.488x |
Annual Cash Flow Conversion Efficiency for NH SPAC 5 (2016–2025)
The table below shows the annual cash flow conversion efficiency of NH SPAC 5 from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see NH SPAC 5 stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩34.18 Billion ≈ $23.16 Million |
₩200.29 Million ≈ $135.74K |
0.006x | +103.74% |
| 2024-12-31 | ₩44.41 Billion ≈ $30.09 Million |
₩-6.96 Billion ≈ $-4.72 Million |
-0.157x | -66.73% |
| 2023-12-31 | ₩79.07 Billion ≈ $53.58 Million |
₩-7.44 Billion ≈ $-5.04 Million |
-0.094x | -239.92% |
| 2022-12-31 | ₩97.63 Billion ≈ $66.16 Million |
₩6.56 Billion ≈ $4.45 Million |
0.067x | +34.09% |
| 2021-12-31 | ₩93.50 Billion ≈ $63.37 Million |
₩4.69 Billion ≈ $3.18 Million |
0.050x | -11.63% |
| 2020-12-31 | ₩75.97 Billion ≈ $51.48 Million |
₩4.31 Billion ≈ $2.92 Million |
0.057x | +536.43% |
| 2019-12-31 | ₩37.06 Billion ≈ $25.12 Million |
₩-481.77 Million ≈ $-326.49K |
-0.013x | +79.43% |
| 2018-12-31 | ₩59.65 Billion ≈ $40.42 Million |
₩-3.77 Billion ≈ $-2.56 Million |
-0.063x | -196.96% |
| 2017-12-31 | ₩60.70 Billion ≈ $41.13 Million |
₩3.96 Billion ≈ $2.68 Million |
0.065x | -82.96% |
| 2016-12-31 | ₩13.63 Billion ≈ $9.23 Million |
₩5.21 Billion ≈ $3.53 Million |
0.383x | -- |
About NH SPAC 5
Inno Instrument Inc. engages in the manufacture and sale of communication equipment worldwide. The company offers fusion splicers; fiber cleavers; test and measurement products, such as optical time domain reflectometers, optical fiber testers, fiber microscopes, and power meters; and 5G and RF solutions, such as 5G spectrum analyzers, 5G distributed antenna systems (DAS), and cable antenna analy… Read more